Prostate cancer and active surveillance

Frontiers of Radiation Therapy and Oncology

Volumn 41, Issue , 2008, Pages 1-6

  Abrahamsson, P A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MALE; PROSTATE TUMOR;

CLINICAL TRIALS AS TOPIC; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 49449093298     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000139867     Document Type: Conference Paper

References (23)

1. Boyle P, Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-488.
2. Schersten T, Baile MA, Asua J, Jonsson E: Prostate Cancer Screening: Evidence Synthesis and Update (INAHTA Joint Project). Vitoria-Gasteiz, Basque Office for Health Technology Assessment, Health Department Basque Government (OSTEBA), 1999.
3. Council of Europe: Recommendation No. R(94)11 on Screening as a Tool of Preventive Medicine. Strasbourg, Council of Europe, 1994.
4. Johansson JE: Expectant management of early stage prostatic cancer: Swedish experience. J Urol 1994;152:1753-1756.
5. Chodak GW, Thisted RA, Gerber GS, et al: Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-248.
6. Albertsen PC, Hanley JA, Gleason DF, Barry MJ: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998;280:975-980.
7. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995;274:626-631.
8. Harris R, Lohr KN: Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:917-929.
9. Holmberg L, Bill-Axelson A, Helgesen F, et al: A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781-789.
10. Bill-Axelson A, Holmberg L, Ruutu M, Häggman M, Andersson SO, Bratell S, Spångberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlén BJ, Johansson JE, Scandinavian Prostate Cancer Group Study No. 4: Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977-1984.
11. Wilt TJ, Brawer MK: Early intervention or expectant management for prostate cancer. The Prostate Cancer Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancer. Semin Urol 1995;13:130-136.
12. Donovan J, Hamdy F, Neal D, et al: Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 2003;7:1-88.
13. Roemeling S, Roobol MJ, Postma R, et al: Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. Eur Urol 2006;50:475-482.
14. Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO: Fifteen-year survival in prostate cancer: a prospective, population-based study in Sweden. JAMA 1997;277:467-471.
15. Brasso K, Friis S, Juel K, Jørgensen T, Iversen P: Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: a population based registry study. J Urol 1999;161:524-528.
16. Aus G, Hugosson J, Norlén L: Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol 1995;154:460-465.
17. Sandblom G, Dufmats M, Varenhorst E: Long-term survival in a Swedish population-based cohort of men with prostate cancer. Urology 2000;56:442-447.
18. Klotz L: Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer. Eur Urol 2005;47:16-21.
19. Klotz L, Nam R: Active surveillance with selective delayed intervention for favourable risk prostate cancer: clinical experience and a 'number needed to treat' analysis. Eur Urol Suppl 2006;5:479-486.
20. Alibhai SMH, Leach M, Tomlinson G, et al: 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity. J Natl Cancer Inst 2005;97:1525-1532.
21. Lu-Yao GL, Albertsen P, Warren J, Yao S-L: Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy - a population-based study. Urology 1999;54:301-307.
22. Slaughter P, Pinfold S, Laupacis A: Prostate-Specific Antigen (PSA) Screening in Asymptomatic Men. Toronto, Institute for Clinical Evaluative Sciences, 2002.
23. Catalona WJ, Carvalhal GF, Mager DE, Smith DS: Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999;162:433-438.